Your browser doesn't support javascript.
loading
Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development.
Raasch, Martin; Fritsche, Enrico; Kurtz, Andreas; Bauer, Michael; Mosig, Alexander S.
Affiliation
  • Raasch M; Institute of Biochemistry II, Jena University Hospital, Germany; Center for Sepsis Control and Care, Jena University Hospital, Germany.
  • Fritsche E; Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany.
  • Kurtz A; Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany.
  • Bauer M; Center for Sepsis Control and Care, Jena University Hospital, Germany; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Germany.
  • Mosig AS; Institute of Biochemistry II, Jena University Hospital, Germany; Center for Sepsis Control and Care, Jena University Hospital, Germany. Electronic address: alexander.mosig@med.uni-jena.de.
Adv Drug Deliv Rev ; 140: 51-67, 2019 02 01.
Article in En | MEDLINE | ID: mdl-29908880
ABSTRACT
Complex cell culture models such as microphysiological models (MPS) mimicking human liver functionality in vitro are in the spotlight as alternative to conventional cell culture and animal models. Promising techniques like microfluidic cell culture or micropatterning by 3D bioprinting are gaining increasing importance for the development of MPS to address the needs for more predictivity and cost efficiency. In this context, human induced pluripotent stem cells (hiPSCs) offer new perspectives for the development of advanced liver-on-chip systems by recreating an in vivo like microenvironment that supports the reliable differentiation of hiPSCs to hepatocyte-like cells (HLC). In this review we will summarize current protocols of HLC generation and highlight recently established MPS suitable to resemble physiological hepatocyte function in vitro. In addition, we are discussing potential applications of liver MPS for disease modeling related to systemic or direct liver infections and the use of MPS in testing of new drug candidates.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Induced Pluripotent Stem Cells / Drug Development / Infections / Liver Diseases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Induced Pluripotent Stem Cells / Drug Development / Infections / Liver Diseases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Year: 2019 Document type: Article